Dengue vaccine gains first major approval

The world’s first single-dose vaccine to prevent dengue fever has been approved for licensure in Brazil, following 16 years of research by scientists at the University of Vermont (UVM) Vaccine Testing Centre, in partnership with the U.S. National Institutes of Health (NIH) and the Johns Hopkins Bloomberg School of Public Health (JHSPH).

Read More